Abstract CT001: Linvoseltamab, a B-cell maturation antigen-targeted T-cell-engaging bispecific antibody, induces deep and durable responses in patients with relapsed or refractory multiple myeloma including difficult-to-treat subgroups

Jagannath, Sundar ; Richter, Joshua ; Dhodapkar, Madhav V. ; Hoffman, James E. ; Lee, Hans C. ; Suvannasankha, Attaya ; Shah, Mansi R. ; Lentzsch, Suzanne ; Zonder, Jeffrey A. ; Baz, Rachid ; Maly, Joseph J. ; Namburi, Swathi ; Wu, Ka Lung ; Pianko, Matthew ; Silbermann, Rebecca ; Min, Chang-Ki ; Vekemans, Marie-Christiane ; Munder, Markus ; Byun, Ja Min ; Lopez, Joaquín Martínez ; DeVeaux, Michelle ; Chokshi, Dhruti ; Boyapati, Anita ; Hazra, Anasuya ; Lorenc, Karen Rodriguez ; Kroog, Glenn S. ; Houvras, Yariv ; Bumma, Naresh

Cancer research (Chicago, Ill.), 2024-04, Vol.84 (7_Supplement), p.CT001-CT001 [Periódico revisado por pares]

Texto completo disponível